AstraZeneca’s offer price is $2.07 per share, the company said in an Oct. 3 news release, making the premium 660 percent and the total purchase price $68 million, according to the Boston Business Journal. Both boards of directors have approved the transaction, which is planned to finalize within four to six weeks.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
